text: Grb2 has been shown to interact with:
  * ADAM15, 
  * Abl gene, 
  * Arachidonate 5-lipoxygenase, 
  * B-cell linker, 
  * BCAR1, 
  * BCR gene, 
  * Beta-2 adrenergic receptor, 
  * C-Met, 
  * CBLB, 
  * CD117, 
  * CD22, 
  * CD28, 
  * CDKN1B, 
  * CRK, 
  * Cbl gene, 
  * Colony stimulating factor 1 receptor, 
  * DCTN1, 
  * DNM1, 
  * Dock180, 
  * Dystroglycan, 
  * EPH receptor A2, 
  * ETV6, 
  * Epidermal growth factor receptor, 
  * Erythropoietin receptor, 
  * FRS2, 
  * Fas ligand, 
  * GAB1, 
  * GAB2, 
  * Glycoprotein 130, 
  * Granulocyte colony-stimulating factor receptor, 
  * HER2/neu, 
  * HNRNPC,
  * Huntingtin, 
  * INPP5D, 
  * IRS1, 
  * ITK, 
  * Janus kinase 1, 
  * Janus kinase 2, 
  * KHDRBS1, 
  * Linker of activated T cells, 
  * Lymphocyte cytosolic protein 2, 
  * MAP2, 
  * MAP3K1 
  * MAP4K1, 
  * MED28, 
  * MST1R, 
  * MUC1, 
  * Mitogen-activated protein kinase 9, 
  * NCKIPSD, 
  * NEU3, 
  * PDGFRB, 
  * PIK3R1, 
  * PLCG1, 
  * PRKAR1A, 
  * PTK2, 
  * PTPN11, 
  * PTPN12, 
  * PTPN1, 
  * PTPN6, 
  * PTPRA, 
  * RAPGEF1, 
  * RET proto-oncogene, 
  * SH2B1, 
  * SH3KBP1, 
  * SHC1, 
  * SOS1, 
  * Src, 
  * Syk, 
  * TNK2, 
  * TrkA, 
  * VAV1, 
  * VAV2, 
  * VAV3,  and
  * Wiskott-Aldrich syndrome protein.